GENES FOR METHY1-BRANCHED WALL LIPIDS AND TUBERCULOSIS
甲基1支化壁脂质和结核病的基因
基本信息
- 批准号:6032391
- 负责人:
- 金额:$ 30.41万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2000
- 资助国家:美国
- 起止时间:2000-01-15 至 2003-12-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Resurgence of tuberculosis (TB) and other mycobacterial infections associated with AIDS threaten human health world-wide. Emergence of drug resistant TB makes it critical to discover new drug targets. Cell walls of Mycobacterium tuberculosis contain a variety of unusual lipids with many types of multiple methyl-branched fatty acids that are unique to pathogenic mycobacteria. These lipids are thought to play important roles in the ability of the pathogens to resist antimicrobial agents and evade the defense reactions of the host. Biosynthesis of these unique lipids containing multiple methyl-branched fatty acids could offer ideal targets for new anti mycobacterial drugs. Genomic sequencing revealed that a remarkably unique feature of the mycobacterial genome is that it contains an unusually large number of genes involved in lipid metabolism. Based on the homology to mycocerosic acid synthase (mas) we have identified two classes of polyketide synthase (pks)-like genes which contain a full complement of active site domains that should be involved in the catalysis of all of the steps required for the synthesis of multimethyl- branched fatty acids: Class 1 mas-like genes mas-like genes (msl1, msl2 and msl3) that are highly homologous to mas and Class 2 (msl4m msl5, msl6 and msl7) which show a lesser degree of homology to mas. These open reading frames (ORFs) most probably encode the more than eight classes of methyl-branched fatty acids found in M. tuberculosis. To elucidate the function of these genes and to examine their possible role in the host-pathogen interaction, we propose to pursue the following specific aims: 1) Determine the functions of Class 1 mas-like genes, ms1, msl2 and msl3 of M. tuberculosis by characterization of their products expressed in M. smegmatis, and by determination of the biochemical and functional consequences of their disruption. 2) Determine the functions of Class 2 (msl4, msl5, msl6 and msl7) mas-like genes in M. tuberculosis genome, by characterization of their products expressed in M. smegmatis, and by determination of the biochemical and functional consequences of their disruption. 3) Determine whether lack of specific lipids caused by the above gene-disruptions affects host-pathogen interaction and virulence. The results will help identify cell wall lipids critical for pathogenesis that might be suitable targets for new anti-mycobacterial drugs.
结核病 (TB) 和其他与艾滋病相关的分枝杆菌感染的死灰复燃威胁着全世界的人类健康。耐药结核病的出现使得发现新的药物靶点变得至关重要。结核分枝杆菌的细胞壁含有多种不寻常的脂质,其中含有多种致病性分枝杆菌所特有的多种甲基支链脂肪酸。这些脂质被认为在病原体抵抗抗菌剂和逃避宿主防御反应的能力中发挥着重要作用。这些含有多个甲基支链脂肪酸的独特脂质的生物合成可以为新型抗分枝杆菌药物提供理想的靶标。基因组测序显示,分枝杆菌基因组的一个显着独特特征是它包含异常大量的参与脂质代谢的基因。基于与真菌蜡曲酸合酶 (mas) 的同源性,我们鉴定了两类聚酮化合物合酶 (pks) 样基因,它们包含完整的活性位点结构域,这些活性位点结构域应参与催化多甲基支化脂肪酸合成所需的所有步骤: 1 类 mas 样基因 与 mas 高度同源的 mas 样基因(msl1、msl2 和 msl3) 和 2 类(msl4m msl5、msl6 和 msl7),与 mas 表现出较低程度的同源性。这些开放阅读框(ORF)很可能编码结核分枝杆菌中发现的八类以上甲基支链脂肪酸。为了阐明这些基因的功能并检查它们在宿主-病原体相互作用中的可能作用,我们建议追求以下具体目标:1)通过表征其在耻垢分枝杆菌中表达的产物的特征,并确定其破坏的生化和功能后果,确定结核分枝杆菌的1类mas样基因ms1、msl2和msl3的功能。 2)通过表征其在耻垢分枝杆菌中表达的产物,并确定其破坏的生化和功能后果,确定结核分枝杆菌基因组中2类(msl4、msl5、msl6和msl7)mas样基因的功能。 3)确定由上述基因破坏引起的特定脂质的缺乏是否影响宿主-病原体相互作用和毒力。这些结果将有助于确定对发病机制至关重要的细胞壁脂质,这些脂质可能是新型抗分枝杆菌药物的合适靶点。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(8)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
PAPPACHAN KOLATTUKUDY KOLATTUKUDY其他文献
PAPPACHAN KOLATTUKUDY KOLATTUKUDY的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('PAPPACHAN KOLATTUKUDY KOLATTUKUDY', 18)}}的其他基金
MCP-1 induced gene expression in cardiovascular disease
MCP-1 诱导心血管疾病基因表达
- 批准号:
6769538 - 财政年份:2002
- 资助金额:
$ 30.41万 - 项目类别:
MCP-1 induced gene expression in cardiovascular disease
MCP-1 诱导心血管疾病基因表达
- 批准号:
6613833 - 财政年份:2002
- 资助金额:
$ 30.41万 - 项目类别:
MCP-1 induced gene expression in cardiovascular disease
MCP-1 诱导心血管疾病基因表达
- 批准号:
6921433 - 财政年份:2002
- 资助金额:
$ 30.41万 - 项目类别:
MCP-1 induced gene expression in cardiovascular disease
MCP-1 诱导心血管疾病基因表达
- 批准号:
6544149 - 财政年份:2002
- 资助金额:
$ 30.41万 - 项目类别:
MCP-1 induced gene expression in cardiovascular disease
MCP-1 诱导心血管疾病基因表达
- 批准号:
6691563 - 财政年份:2002
- 资助金额:
$ 30.41万 - 项目类别:
GENES FOR METHY1-BRANCHED WALL LIPIDS AND TUBERCULOSIS
甲基1支化壁脂质和结核病的基因
- 批准号:
6488748 - 财政年份:2000
- 资助金额:
$ 30.41万 - 项目类别:
Search for novel TB Drug Targets in Lipid Metabolism
寻找脂质代谢中的新型结核病药物靶点
- 批准号:
7339329 - 财政年份:2000
- 资助金额:
$ 30.41万 - 项目类别:
GENES FOR METHY1-BRANCHED WALL LIPIDS AND TUBERCULOSIS
甲基1支化壁脂质和结核病的基因
- 批准号:
6626371 - 财政年份:2000
- 资助金额:
$ 30.41万 - 项目类别:
Search for novel TB Drug Targets in Lipid Metabolism
寻找脂质代谢中的新型结核病药物靶点
- 批准号:
6830769 - 财政年份:2000
- 资助金额:
$ 30.41万 - 项目类别:
Search for novel TB Drug Targets in Lipid Metabolism
寻找脂质代谢中的新型结核病药物靶点
- 批准号:
6723620 - 财政年份:2000
- 资助金额:
$ 30.41万 - 项目类别:
相似国自然基金
鲜驴乳中游离脂肪酸对Mycobacterium tuberculosis H37Rv活性的影响及机制研究
- 批准号:31760442
- 批准年份:2017
- 资助金额:38.0 万元
- 项目类别:地区科学基金项目
相似海外基金
Fragment to small molecule hit discovery targeting Mycobacterium tuberculosis FtsZ
针对结核分枝杆菌 FtsZ 的小分子片段发现
- 批准号:
MR/Z503757/1 - 财政年份:2024
- 资助金额:
$ 30.41万 - 项目类别:
Research Grant
Functional exploration of a deep Mycobacterium tuberculosis phosphoproteome
结核分枝杆菌深层磷酸蛋白质组的功能探索
- 批准号:
10656957 - 财政年份:2023
- 资助金额:
$ 30.41万 - 项目类别:
The role of the gut microbiome in susceptibility to Mycobacterium tuberculosis
肠道微生物组在结核分枝杆菌易感性中的作用
- 批准号:
10647554 - 财政年份:2023
- 资助金额:
$ 30.41万 - 项目类别:
Optimizing Multi-drug Mycobacterium tuberculosis Therapy for Rapid Sterilization and Resistance Suppression
优化结核分枝杆菌多药治疗以实现快速灭菌和耐药性抑制
- 批准号:
10567327 - 财政年份:2023
- 资助金额:
$ 30.41万 - 项目类别:
Analysis of essentiality of thymidylate synthase and methionine adenosyltransferase in Mycobacterium tuberculosis
结核分枝杆菌胸苷酸合酶和甲硫氨酸腺苷转移酶的必要性分析
- 批准号:
23K14522 - 财政年份:2023
- 资助金额:
$ 30.41万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Structural characterization of MCE transport systems from Mycobacterium tuberculosis
结核分枝杆菌 MCE 转运系统的结构表征
- 批准号:
10681871 - 财政年份:2023
- 资助金额:
$ 30.41万 - 项目类别:
Impact of Mycobacterium tuberculosis on monocyte differentiation in vivo
结核分枝杆菌对体内单核细胞分化的影响
- 批准号:
10606380 - 财政年份:2023
- 资助金额:
$ 30.41万 - 项目类别:
Elucidation of factors affecting environmental persistence of non-tuberculous Mycobacterium tuberculosis and related genomic factors
影响非结核分枝杆菌环境持久性的因素及相关基因组因素的阐明
- 批准号:
23H00451 - 财政年份:2023
- 资助金额:
$ 30.41万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
Structural basis for the induction of dormancy in Mycobacterium tuberculosis
结核分枝杆菌休眠诱导的结构基础
- 批准号:
23H02417 - 财政年份:2023
- 资助金额:
$ 30.41万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
SIGMA: Small molecule Inhibitors targeting the Genetic determinants of Mutagenesis and Adaptability in Mycobacterium tuberculosis
SIGMA:针对结核分枝杆菌突变和适应性的遗传决定因素的小分子抑制剂
- 批准号:
EP/X032817/1 - 财政年份:2023
- 资助金额:
$ 30.41万 - 项目类别:
Research Grant